SCHEMBL3759743

SCHEMBL3759743

NC(=O)N1C=CC=NC=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2338031 0.80
SCHEMBL30491972 0.78
SCHEMBL31061897 0.74
SCHEMBL5672376 0.73
SCHEMBL3904518 0.70
SCHEMBL4255620 0.66 HTT (0.34)
SCHEMBL30491916 0.65
SCHEMBL31745346 0.64
SCHEMBL5901136 0.61
SCHEMBL932027 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117384140-B Benzimidazole derivative and application thereof 沈阳药科大学 2024-10-11 CN disclosed
CN-117384140-A Benzimidazole derivative and application thereof 沈阳药科大学 2024-01-12 CN disclosed
CN-116635378-A Bicyclic 1, 4-diazacycloheptanones and therapeutic uses thereof 赛特凯恩蒂克公司 2023-08-22 CN disclosed
US-20190142810-A1 MITOCHONDRIAL INHIBITORS FOR THE TREATMENT OF PROLIFERATION DISORDERS BASILEA PHARM INT AG (CH) 2019-05-16 US disclosed
CN-109661392-A For treating the mitochondrial inhibitors of proliferative disorder 巴斯利尔药物国际股份公司 2019-04-19 CN disclosed
EP-2170350-A2 SUBSTITUTED IMIDAZOHETEROCYCLES Cara Therapeutics, Inc. (US) 2010-04-07 EP disclosed
WO-2008157751-A2 SUBSTITUTED IMIDAZOHETEROCYCLES CARA THERAPEUTICS, INC. (US) 2008-12-24 WO disclosed